Sort   by:  
 Page size 
UnknownEffect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Not available
S-EPMC11115458 | biostudies-literature
UnknownEmpagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.
Not available
S-EPMC11955319 | biostudies-literature
UnknownEmpagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI.
Not available
S-EPMC12719805 | biostudies-literature
UnknownMixed Methods Analysis of Implementation of Interpersonal Psychotherapy (IPT) for Major Depressive Disorder in Prisons in a Hybrid Type I Randomized Trial.
Not available
S-EPMC9187220 | biostudies-literature
UnknownIL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.
Not available
S-EPMC3273545 | biostudies-literature
UnknownStudy Protocol: A randomized controlled trial of suicide risk reduction in the year following jail release (the SPIRIT Trial).
Not available
S-EPMC9236190 | biostudies-literature
UnknownDesign and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making.
Not available
S-EPMC11503019 | biostudies-literature
UnknownTwo Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000 | biostudies-literature
UnknownThe SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.
Not available
S-EPMC9018422 | biostudies-literature
UnknownRacial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Not available
S-EPMC10523916 | biostudies-literature
Sort   by:  
 Page size